Identification and analysis of cation channel homologues in human pathogenic fungi

David L Prole1, Colin W Taylor

  • 1Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge, United Kingdom. dp350@cam.ac.uk

Plos One
|August 10, 2012
PubMed

Insights

Pathogenic fungi possess limited cation channels, unlike humans. These fungal channels differ in sequence, offering potential targets for new antifungal drugs to combat widespread drug resistance.

Area of Science:

  • Mycology
  • Molecular Biology
  • Drug Discovery

Background:

  • Fungal infections pose significant health risks, with limited therapeutic options and increasing antifungal drug resistance.
  • Genomic sequencing of fungal pathogens enables the identification of novel drug targets.
  • Cation channels are established targets for therapeutic intervention.

Purpose of the Study:

  • To investigate the presence and characteristics of cation channel homologues in human fungal pathogens.
  • To identify potential novel drug targets for antifungal therapies by comparing fungal and human channel proteins.

Main Methods:

  • Comparative genomic analysis of human fungal pathogens.
  • Identification and characterization of genes encoding potassium (K(+)), calcium (Ca(2+)), and transient receptor potential (Trp) channel homologues.
  • Sequence comparison of fungal channels with their human counterparts.

Main Results:

  • Fungal genomes encode homologues of K(+), Ca(2+), and Trp channels, but lack sodium (Na(+)) and ligand-gated channels.
  • Specific fungal pathogens like *Aspergillus* spp. and *Cryptococcus* spp. possess mitochondrial calcium uniporter (MCU) homologues.
  • Pathogenic fungi exhibit a significantly reduced repertoire of K(+), Ca(2+), and Trp channels compared to humans.
  • Fungal channel sequences display distinct regions compared to human channels, suggesting differential regulation and drug susceptibility.

Conclusions:

  • Pathogenic fungi possess a limited and distinct set of cation channels compared to humans.
  • These identified fungal cation channel homologues represent promising targets for the development of novel antifungal drugs.
  • Differences in channel structure may explain differential drug responses and guide the design of targeted therapies.